MktsMarkets

Shuttle Pharmaceuticals Holdings, Inc.
NASDAQ: SHPHKey statistics
SHPH News
Stories mentioning SHPH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 267.00 | 512.00 | 943.00 | 1,026 | 1,574 | 986.00 | 1,401 | 646.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,217 | 2,789 | 2,267 | 3,910 | 2,951 | 1,776 | 3,052 | 1,483 |
| Operating Income (Loss) | (2,217) | (2,789) | (2,267) | (3,910) | (2,951) | (1,776) | (3,052) | (1,483) |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 14.00 | ||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,152) | (2,616) | (2,347) | (3,706) | (3,053) | (1,599) | (3,784) | (2,031) |
| Earnings Per Share (Basic) | (0.43) | (1.60) | (1.05) | (3.29) | (7.60) | (13.90) | (39.83) | (24.12) |
| Earnings Per Share (Diluted) | (0.43) | (1.60) | (1.05) | (3.29) | (7.60) | (13.90) | (39.83) | (24.12) |
| Weighted Average Shares Outstanding (Basic) | 5,032 | 1,638 | 2,234 | 1,126 | 402.00 | 115.00 | 95.00 | 84.00 |
| Weighted Average Shares Outstanding (Diluted) | 5,032 | 1,638 | 2,234 | 1,126 | 402.00 | 115.00 | 95.00 | 84.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SHPH
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol SHPH. It last traded at $5.34 (Nov 10, 2026, 4:00 PM ET), up 2.9% on the day. That gives Shuttle Pharmaceuticals a market capitalisation of $24.7M.
Over the past 52 weeks SHPH has traded between $2.58 and $44.40.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.2M |
| Dec 31, 2025 | — | -$2.6M |
| Sep 30, 2025 | — | -$2.3M |
| Jun 30, 2025 | — | -$3.7M |
From Shuttle Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…